Table 2.

Operative characteristics of patients having interval cytoreductive surgery (n = 25).

Operative characteristic	N (%), mean ± SD (range)
Degree of cytoreduction •No visible residual •Optimal •Suboptimal •Unresectable/aborted	•13 (52%) •7 (28%) •3 (12%) •2 (8%)
Mode of operation: •Laparotomy •Laparoscopy	•20 (80%) •5 (20%)
Hysterectomy + bilateral salpingo-ophorectomy •Yes •No*	•23 (92%) •2 (8%)
Omentectomy •Yes •No	•16 (64%) •9 (36%)
Lymphadenectomy (pelvic or para-aortic) •Yes •No	•2 (8%) •23 (92%)
Upper abdominal debulking •Yes •No	•1 (4%) •24 (96%)
Additional cytoreductive procedures •Yes •No	•6 (24%) •19 (76%)
Bowel resection (small or large bowel) •Yes •No	•5 (20%) •20 (80%)
Number of bowel resections •Small bowel •Large bowel	•4 •3
Intra-operative complication •Yes •No	•1 (4%) •24 (96%)
Operative time (minutes)	184 ± 76 (90–354)
Estimated blood loss (mL)	284 ± 181 (15–600)
Post-operative histology on final pathology •Endometrioid •Serous •Clear cell •Carcinosarcoma •Mixed •Other	•7 (28%) •12 (48%) •1 (4%) •1 (4%) •3 (12%) •1 (4%)
Treatment response seen on final pathology •Yes •No •Not specified	•4 (16%) •2 (8%) •19 (76%)
Post-operative FIGO stage •IIIC2 •IVB	•1 (4%) •24 (96%)

SD = standard deviation, FIGO = international federation of gynecology and obstetrics.

^*Both operations aborted prior to hysterectomy due to unresectable disease.